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It is becoming a consensus that white matter integrity is compromised in schizophrenia
(SZ), however the underlying genetics remains elusive. Evidence suggests a polygenic
basis of the disorder, which involves various genetic variants with modest individual effect
sizes. In this work, we used a multivariate approach, parallel independent component
analysis (P-ICA), to explore the genetic underpinnings of white matter abnormalities in
SZ. A pre-filtering step was first applied to locate 6527 single nucleotide polymorphisms
(SNPs) discriminating patients from controls with a nominal uncorrected p-value of 0.01.
These potential susceptibility loci were then investigated for associations with fractional
anisotropy (FA) images in a cohort consisting of 73 SZ patients and 87 healthy controls
(HC). A significant correlation (r = −0.37, p = 1.25 × 10−6) was identified between one
genetic factor and one FA component after controlling for scanning site, ethnicity, age, and
sex. The identified FA-SNP association remained stable in a 10-fold validation. A 5000-run
permutation test yielded a p-value of 2.00 × 10−4. The FA component reflected decreased
white matter integrity in the forceps major for SZ patients. The SNP component was
overrepresented in genes whose products are involved in corpus callosum morphology
(e.g., CNTNAP2, NPAS3, and NFIB) as well as canonical pathways of synaptic long term
depression and protein kinase A signaling. Taken together, our finding delineates a part of
genetic architecture underlying SZ-related FA reduction, emphasizing the important role of
genetic variants involved in neural development.
Keywords: diffusion tension imaging (DTI), fractional anisotropy (FA), parallel independent component analysis
(P-ICA), single nucleotide polymorphisms (SNPs), schizophrenia
INTRODUCTION
Schizophrenia (SZ) is a severe, debilitating mental disorder
with heritability estimated up to ∼80% (Sullivan et al., 2003).
However, its genetic basis remains elusive. The last decade has
seen a large number of genome wide association studies (GWAS)
searching for genetic variants regulating the liability for SZ
(Gejman et al., 2011). More recently, very large sample sizes
have been made possible with aggregated data through collab-
orative consortia, yielding more reliable and replicable findings
(Visscher et al., 2012). Indeed, evidence accumulates to suggest
the polygenicity of SZ, where genetic variants with subtle effects
may function together to confer the liability (Purcell et al., 2009,
2014; Giusti-Rodriguez and Sullivan, 2013). One estimation is
that, together, genome-wide SNPs capture 23% of the variation
in SZ liability, a substantial portion of which is due to common
variants (Lee et al., 2012). Obviously, the combined effect of mul-
tiple variants is more prominent than those of individuals SNPs
and hence more likely to be identifiable. In this sense, multivari-
ate approaches assessing multiple variables for aggregate effects
appear to be better positioned for modeling the polygenic basis
of SZ.
Given the complexity and heterogeneity of SZ, one valuable
strategy to unravel the genetic risk is through investigating the
effects of genetic variants on intermediate phenotypes such as dis-
rupted brain structure and function, which are more proximal to
biological mechanisms compared to behavioral measures (Rose
and Donohoe, 2013). In the last two decades notable progress
has been made in mapping gray matter abnormalities in SZ.
The investigation of white matter integrity was lagging behind
until the advancement in magnetic resonance diffusion imaging
(MR-DI) technique affords characterizing fiber tract direction
and organization. One can model these data with a single ten-
sor model in which a diffusion tensor is estimated for water
molecules at each voxel to derive metrics of anisotropy which
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infer fiber properties and can be compared across subjects for
associations with other traits of interest. With this technique and
more complex multiple tensor or diffusion spectrum imaging
techniques applied to SZ studies, there is consensus that white
matter integrity is compromised in affected patients, including
decreased fractional anisotropy (FA) in prefrontal and tempo-
ral lobes, as well as the fiber bundles connecting these regions
(Kubicki et al., 2007). In addition, family studies further showed
a genetic factors might underlie the FA deficits, which were
also observed, with a lower extent, in unaffected relatives of
patients (Hoptman et al., 2008; Maniega et al., 2008; Clark et al.,
2011).
These previous findings strongly indicate FA deficits as a her-
itable biomarker for SZ. However, to our knowledge, there has
not been enough work characterizing the genetic aspects, and
this is what motivated the current study. We studied 73 SZ
patients and 87 controls with good-quality genome-wide SNP
data and FA images. A pre-filtering step was applied to locate
SNPs which show a weak differentiation of patients from controls.
These potential causal loci were then analyzed for associations
with FA images using parallel independent component analysis
(P-ICA) (Liu et al., 2009; Liu and Calhoun, 2014). As a multivari-
ate approach, P-ICA extracts genetic and imaging components,
respectively from the SNP data and FA images to capture clus-
ters of SNPs or voxels exhibiting co-variations across subjects
which simultaneously emphasizing imaging-genetic associations
in order to identify genetic factors explaining FA variation. This
approach also enables us to study genetic variants clustered into
components at a pathway level, potentially providingmore insight
into the underpinnings of SZ. To guard against false discoveries,
the identified FA-SNP associations were evaluated with 10-fold
validation and permutation tests.
MATERIALS AND METHODS
PARTICIPANTS
The Mind Clinical Imaging Consortium (MCIC), a collabo-
rative effort of four research teams from New Mexico (NM),
Boston (MGH), Iowa (IOWA), and Minnesota (MINN) was
involved in subject recruitment and data collection (Gollub
et al., 2013). The number of healthy controls/patients with
schizophrenia were balanced and matched for age/gender as
much as possible. Only participants having good quality DTI
and GWS data were considered. Each site’s institutional review
board approved the study and all the participants provided
written informed consents. Healthy participants were screened
to ensure that they were free of any neurological, medical or
psychiatric illnesses, including any history of substance abuse.
Structured clinical interviews for DSM-IV (SCID) and case file
reviews confirmed a diagnosis of schizophrenia for the patients
(Williams et al., 1992). A total of 160 participants who had
volunteered for DTI and gene testing were included in this
work, including 73 SZ patients and 87 healthy controls (see
Table 1 for demographic information). We admitted all ethnic
groups (self-reported) to maximize the sample size. Ethnicity
information was missing for eight participants but was inferred
based on the genetic data using principal component analysis
(PCA).
Table 1 | Demographic information of patients with schizophrenia
and healthy controls.
Demographics SZ (73) HC (87)
Sex Male 54 51
Female 19 36
Age Mean ± SD 34 ± 11 32 ± 11
Ethnicity Caucasian 53 81
Asian 5 3
American Indian or Alaska Native 1 0
African-American 14 3
DTI IMAGE ACQUISITION AND PREPROCESSING
The image acquisition parameters are summarized in Table 2
(White et al., 2011). Prior to diffusion tensor calculation, images
went through standard preprocessing (Caprihan et al., 2011).
DTI preprocessing included three steps: (1) Data quality check:
Subjects with signal dropouts caused by motion or presence of
striated artifacts on images were not included in the study. (2)
Motion and eddy current correction:We registered all the images to
a b =0 sec/mm2 image. Twelve degrees of freedom, affine trans-
formation with mutual information cost function was used for
image registration. (3) Adjusting the diffusion gradient direction:
Two corrections were applied to the diffusion gradients. The
nominal diffusion gradient directions were prescribed in themag-
net axis frame. We rotated them to correspond to the image slice
orientation. No correction was required if the imaging slice was
pure axial. A second correction accounted for any image rotation
during the previous motion and eddy current correction step.
The rotation part of the transformation found previously was
extracted, and each gradient direction vector corrected accord-
ingly. All the image registration and transformations were done
with the FLIRT (FMRIB’s Linear Image Registration Tool) pro-
gram [FMRIB Software Library (FSL); www.fmrib.ox.ac.uk/fsl].
Dtifit, a tool in FSL, was adopted to calculate the diffusion ten-
sor and the fractional anisotropy (FA) maps. The FA image was
aligned to a MNI FA template with a non-linear registration algo-
rithm FNIRT (FMRIB’s Non-linear Image Registration Tool; FSL)
and resliced via SPM resulting in a final voxel size of 2 × 2 ×
2mm. After preprocessing, the FA maps were smoothed using
8mm smoothing kernel (Jones et al., 2005).
We noticed significant differences in data collected at one site,
which might be related to a cohort effect or greater variability
due to fewer DTI directions. With site coded as dummy variable,
we performed a voxelwise regression on FA images using Matlab,
thereby eliminating the site effects. Site-by-diagnosis interactions
were checked post-hoc after P-ICA decomposition using the FA
loadings.
SNP DATA COLLECTION AND PREPROCESSING
The genotyping and genetic quality control procedures were
same as described in our previous work (Chen et al., 2012b),
which is briefly discussed here. DNA was extracted from a blood
sample collected at individual sites. Genotyping for all sub-
jects was performed at the Mind Research Network using the
Illumina InfiniumHuman Omni1-Quad assay spanning a total of
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Table 2 | DTI acquisition parameters at four sites for MCIC study.
Scanning parameter Site 1 Site 2 Site 3 Site 4
Scanner (Tesla) Siemens (1.5) GE Signa (1.5) Siemens Trio (3) Siemens (1.5)
TR (ms) 9500 8900 10,500 9800
TE (ms) 90 80 98 86
Voxel dimensions (mm) 2 × 2 × 2 2 ×2 × 2 2 × 2 × 2 2 × 2 × 2
Diffusion directions 6 60 12 12
B-values (s/mm2) 0/1000 0/700 0/1000 0/1000
NEX 4 1 2 4
Bandwidth (Hz/pixel) 1954 1860 1342 1502
TR, repetition time; TE, echo time; NEX, number of excitations.
1,140,419 SNP loci. BeadStudio was used to make the final geno-
type calls and PLINK (Purcell et al., 2007) was employed for a
series of quality controls (Anderson et al., 2010) including: (a)
gender consistency check, (b) sample relatedness (not closer than
second degree relatives), (c) genotyping call rate (>90% at both
the individual and SNP level), (d) Hardy–Weinberg equilibrium
in the control population (p < 1 × 10−6), (e) minor allele fre-
quency (MAF > 0.05), and (f) missing calls were replaced using
high linkage disequilibrium (LD) loci if available or otherwise
removed. A total of 777,365 SNP loci were retained after quality
control and discrete numbers were then assigned to the categor-
ical genotypes: 0 (no minor allele), 1 (one minor allele), and 2
(two minor alleles). With PCA, two principal components were
identified as ethnicity-related and eliminated from the data. No
clear population structure was observed in the corrected data.
ALGORITHM FOR EXTRACTION OF LINKAGES IN MULTIMODAL
DATASETS
P-ICA first extracts components from the two modalities in par-
allel based on infomax ICA (Bell and Sejnowski, 1995), and then
enhances the correlations between pairs of components loadings.
The following Equations (1) and (2) describe the mathematical
model of Infomax. For each modality, the data are decomposed
into a linear combination of underlying components. X1 and
X2 represents the FA and SNP modalities; S1 and S2 represents
the underlying independent components, while A1 and A2 rep-
resent the mixing matrix/loadings for FA and SNP modalities; W
denotes the un-mixing matrix, which is the (pseudo) inverse of
A. Equation (3) illustrates the objective function of entropy and
correlations computed between columns of loadings matrices A1
and A2. fy(Y) is the probability density function of Y ; E is the
expected value; H is the entropy function; W0 is the bias vector.
W is then iteratively updated based on the natural gradient rule to
optimize the objective function. A full description as well as the
mathematical/simulation details of the algorithm can be found
in our previous publications (Liu et al., 2008, 2009; Chen et al.,
2012a) and the algorithm is available in the fusion ICA toolbox
(FIT) (http://mialab.mrn.org/software/fit).
X1 = A1 · S1
W
1=A−11−→ S1 = W1 · X1 (1)
X2 = A2 · S2
W
2=A−12−→ S2 = W2 · X2 (2)
max{H (Y1) + H (Y2) + [corr (A1, A2)]2} =
{
− E [lnfy (Y1)]−
E
[
lnfy (Y2)
] + cov
(
A1i, A2j
)2
var (A1i) · var
(
A2j
)
}
Y = 1
1 + e−U ; U = WX + W0 (3)
P-ICA yields best performances when the ratio of sample size to
the number of variables is above 0.02 for the genetic modality
(Liu et al., 2008). Consequently, a pre-filtering step was con-
ducted to locate 6527 SNPs, discriminating patients from controls
with p-values less than 0.01 uncorrected. These potential suscep-
tibility loci were then analyzed for associations with neurobio-
logical traits. The component number was estimated to be nine
for the FA modality using minimum description length (MDL)
(Rissanen, 1978). The SNP component number was estimated
to be seven based on component consistency as in Chen et al.
(2012a). P-ICA was performed through the Fusion ICA Toolbox
(FIT, http://mialab.mrn.org/software/fit/index.html). The algo-
rithm was configured with a threshold of 0.3 for constrained
correlations to avoid false positive associations and to only con-
strain one pair of components. The endurance parameter was set
to −1 × 10−5 to control the decreasing slope of the entropy term
and avoid over fitting. We performed two independent P-ICA
decompositions, one with the entire dataset (i.e., 73 Sz and 87
HC) and the second using Caucasian participants only (i.e., 53 Sz
and 81 HC). We also performed association analysis between the
FA/SNP loadings and the Positive and Negative Syndrome Scale
(PANSS) symptoms as well as medication.
PERMUTATION AND 10-FOLD CROSS VALIDATION TESTS
We performed a permutation test to assess the validity of iden-
tified FA-SNP association by investigating the occurrences of
inter-modality correlations by chance in permuted FA and SNP
datasets. The null distribution was constructed with the top corre-
lation obtained from each test run. We then counted the instances
with correlations greater than that observed from the original
data and calculated the tail probability as the significance level.We
also performed a 10-fold cross-validation to examine the repro-
ducibility of the identified FA-SNP association using a subset of
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90% subjects. The same P-ICA parameters were used for all subset
P-ICA decompositions.
RESULTS
P-ICA identified one FA-SNP pair components presenting a sig-
nificant correlation (r = −0.37, p = 1.25 × 10−6) and passing
the Bonferroni threshold of 7.93 ×10−4, after controlling for
age/sex and correcting for 63 independent tests. The FA-SNP
pair replicated in all 10-fold validations having a correlation
range of 0.18–0.46 and a median of 0.33. The FA and SNP
components identified in subset decompositions in 10-fold cross-
validation showed similar patterns to those identified with the
entire dataset. The overlapping ratio refers to the percentage
replication of the associated SNP component from the entire
dataset with the associated SNP component in various subset
decompositions. The overlapping ratio was around 50–70% in
the various subset decompositions. Though variability existed
in SNP component from entire dataset and subset decompo-
sitions, the genes/pathways obtained were very similar. Hence
the final set of associated SNPs was selected from the results of
entire dataset. In a 5000-run permutation test, the absolute val-
ues of FA-SNP top correlations ranged from 0.11 to 0.43 with
a median of 0.19, yielding a p-value of 2.00 × 10−4 and passing
the Bonferroni threshold of 7.93 × 10−4 for the identified associ-
ation. We further examined the FA-SNP association within the SZ
and HC groups, respectively, and observed a partial FA-SNP cor-
relation of −0.1304 (p = 0.27) within the schizophrenia patients
and −0.0019 (p = 0.98) within the healthy controls.
Figure 1A illustrates the spatial map of highlighted brain
regions when the linked FA component was thresholded at
|Z|> 3.5, covering 55% of the forceps major tract. The group
mean of FA loadings was significantly lower in the patients with
schizophrenia (p = 8.51 × 10−9), as shown in Figure 1B, reflect-
ing decreased FA in SZ patients in the forceps major. The same
direction of group mean for FA loadings (i.e., healthy controls
> patients with schizophrenia) was observed at all four sites,
thereby indicating no site by diagnosis interaction. We did not
observe any significant FA associations with patient symptoms
or chlorpromazine equivalent medication scores calculated from
all current medications, which is presented in Table 3. A recent
diffusion MRI study in schizophrenia reported an association
between visual hallucinations and the microstructure of forceps
major (Amad et al., 2013). Our dataset included 20 partici-
pants (i.e., within 73 Sz) who had a Global Rating of Severity of
Hallucinations (GR_Hallu) greater than three (Range being 0–5;
with five indicating most severe). On trying to replicate this how-
ever, we could not find any correlations between GR_Hallu and
the FA loadings in this complementary analysis, which could be
due to the very small sample size.
The linked SNP component depicted in Figure 1C also showed
significant group difference (p = 1.62 × 10−32) as expected, since
the SNPs for P-ICA were selected based on group difference. As
in Figure 1B, patients presented positive loadings while controls
presented negative loadings. This component was predominantly
contributed to by 326 SNPs (top 5% based on absolute values
of component weights). These SNPs, their host genes, z-scores
of component weight, original genotypic group difference and
minor allele frequencies (MAFs) in patient and control groups
are indicated in Table S1. One hundred and sixty three SNPs
were mapped to 90 unique genes using SNPnexus (www.snp-
nexus.org), while the rest were from inter-genic regions. We also
examined the genetic architecture of our finding using Ingenuity
Pathway Analysis (IPA: https://www.ingenuity.com) where the 90
genes were compared with the whole genome as background.
IPA identified enrichment in abnormal morphology of corpus
callosum with gene hits in CNTNAP2, NFIB, and NPAS3 (p =
2.78 × 10−4), as illustrated in Table 4A. IPA also revealed a num-
ber of enriched canonical pathways, including synaptic long term
depression (LTD) (p = 8.71 × 10−4) and protein kinase A (PKA)
signaling (p = 1.02 × 10−3), as shown in Table 4B.
We also analyzed the FA-SNP pair obtained from the inde-
pendent secondary P-ICA decomposition (i.e., considering cau-
casians participants), observing the FA component covered the
same region of forcep majors as obtained with the entire dataset.
The overlapping ratio of snps between SNP components (i.e.,
between caucasians only and the entire dataset P-ICA decom-
positions) was around 30%. Our previous studies have shown
that this overlap with such small sample size is much higher than
random (Chen et al., 2012a,b). We also observed a high correla-
tion of -0.35 between the top paired FA and SNP loadings in this
caucasians only decomposition.
DISCUSSION
In this study we investigated the genetic underpinnings of white
matter abnormalities in SZ. A multivariate approach, P-ICA, was
used to extract SNP and FA components, and retrieve inter-
modality associations. Due to the limited sample size compared
to genome-wide SNPs, we preselected 6527 risk loci based upon
group difference to focus the FA-SNP association analysis on
polymorphisms likely relevant to SZ. This strategy could bias the
significance level of group difference in the SNP component, but
not the significance of identified FA-SNP correlations. Finally one
significant FA-SNP pair was identified with its validity confirmed
by the permutation test and 10-fold cross validation.
The identified FA component highlighted forceps major with
the loadings indicating lower FA-values in SZ than HC. Forceps
major fibers are located in the posterior end of the corpus cal-
losum (CC), also known as splenium. These fibers interconnect
bilateral parietal and occipital (dorsal portion), as well as tempo-
ral cortices (ventral portion) (Park et al., 2008). There is a growing
body of evidence that FA is decreased in splenium for SZ patients
(Cheung et al., 2008; Gasparotti et al., 2009; Knoche et al., 2012;
Ellison-Wright et al., 2014), which has also been confirmed in
meta-analyses (Ellison-Wright and Bullmore, 2009; Patel et al.,
2011). Splenium was also identified to show decreased FA in an
ICA based study (Caprihan et al., 2011). Note that this local
FA reduction is observed in both chronic and non-medicated
first-episode patients, indicating a low possibility of medication
effect, consistent with no association being observed between the
FA loadings and the medication dosages in our study. Instead,
the lower FA may be a consequence of demyelination or axon
loss (Alexander et al., 2007), which coincides with the reports
of SZ-related reduction in volume of CC and the subregion of
splenium (Arnone et al., 2008; Francis et al., 2011). Additionally,
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FIGURE 1 | (A) FA component corresponding to Top P-ICA pair. (B)
Scatter plots of FA and SNP loadings (both SZ and HC participants)
from P-ICA with the regression line. The group mean directionality
being HC > SZ. (C) Z-scored SNP component corresponding to Top
P-ICA pair. Horizontal lines indicate the threshold to obtain the top
5% SNPS.
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Table 3 | Summary of clinical information.
Number of Sz % Reporting DOI % Reporting PANSS % Reporting PANSS % Reporting Cpz eqvt of all
duration of Mean (PANSS positive (PANSS negative medication current
illness (DOI) ± SD positive) Mean ± SD negative) Mean ± SD medications (mg/day)
73 95.89 11.18 ± 10.5 97.26 15.94 ± 4.9 97.26 16.06 ± 4.9 91.78% 653.52 ± 684.14
Table 4 | Ingenuity pathway analysis on the SNP component.
p-Value Molecules
A. DISEASES OR FUNCTIONS ANNOTATION
Abnormal morphology of brain 6.96E-03 CNTNAP2, FA2H, GRID2, LRRTM4, NPAS3, NFIB
Abnormal morphology of corpus callosum 2.78E-04 CNTNAP2, NPAS3, NFIB
Abnormal morphology of hippocampus 5.11E-03 LRRTM4, NPAS3, NFIB
Morphology of brain cells 6.59E-03 FA2H, GRID2, NFIB
B. CANONICAL PATHWAYS
Synaptic long term depression 8.71E-04 GRID2, RYR3, RYR2, PRKCB
Protein kinase A signaling 1.02E-03 PTPRD, RYR3, RYR2, CREB5, PTPRM, PRKCB
Gαs signaling 4.79E-03 RYR3, RYR2, CREB5
Hepatic cholestasis 8.71E-03 SLCO3A1, FABP6, PRKCB
CREB signaling in neurons 1.58E-02 GRID2, CREB5, PRKCB
Calcium signaling 1.74E-02 RYR3, RYR2, CREB5
family and twin studies suggest the FA reduction in splenium
and alterations in CC structure are likely regulated by genetics
(Pfefferbaum et al., 2001; Francis et al., 2011; Knoche et al., 2012).
Overall, the identified imaging component revealed a white mat-
ter biomarker robustly identified to characterize SZ while also
exhibiting heritability.
A negative FA-SNP correlation was observed; reflecting par-
ticipants with SZ carrying higher loadings of specific genotypes
had lower FA-values in forceps major fibers. Corresponding to
the FA findings in splenium, the SNP component was overrepre-
sented in networks affecting the abnormal morphology of corpus
callosum, involving CNTNAP2, NPAS3, and NFIB genes, as in
Table 4A. CNTNAP2 encodes a neurexin protein involved in neu-
ron interaction and axon differentiation. SNPs in CNTNAP2 have
shown associations with FA in uncinated fasciculus (rs2710126)
(Clemm von Hohenberg et al., 2013) as well as graph measures
of structural brain connectivity including small-worldness and
global efficiency (rs2710102) (Dennis et al., 2011). A copy num-
ber variation disrupting CNTNAP2 is also suggested to play a role
in SZ (Friedman et al., 2008). The NPAS3-encoded protein reg-
ulates neurodevelopment (Sha et al., 2012) and NPAS3-deficient
mice exhibited hypoplasia of CC (Brunskill et al., 2005). Common
SNPs in NPAS3 have also been associated with SZ (Macintyre
et al., 2010). The transcription factor NFIB is demonstrated to
play a central role in thematuration of midline glia and formation
of CC inmouse studies (Piper et al., 2009). One speculation based
on our finding is that these identified SNPs affect white matter
integrity through regulating brain development, and SZ patients
tend to carry more risk genotypes for low white matter integrity.
The SNP component was also enriched in PKA signaling,
involving CREB, PRKCB, RYR2, RYR3, PTPRD, and PTPRM, as
in Table 4B. Cyclic AMP-dependent protein kinase (PKA) is an
enzyme responsible for the phosphorylation of numerous ner-
vous system proteins (Daniel et al., 1998), thus it is involved
in various mechanisms including axon guidance and myelina-
tion (Yoon et al., 2008; Murray et al., 2009). For instance, PKA
promotes the phosphorylation of CREB which regulates the
transcription of BDNF, a protein documented in neurogenesis,
axon guidance and synaptic plasticity (Cohen-Cory et al., 2010).
Indeed, CREB has a pivotal role in cellular processes and is
implicated in a wide spectrum of disorders including SZ (Yuan
et al., 2010; Saura and Valero, 2011). PRKCB encodes calcium-
dependent protein kinase (PKC) beta whose activity is shown
to modulate myelin gene expression in enriched oligodendro-
cytes (Asotra and Macklin, 1993) and mediate axon regeneration
(Sivasankaran et al., 2004). PKC beta is also observed to exhibit
disrupted expression in chronic SZ (Hakak et al., 2001). RYR2
and RYR3 encode ryanodine receptors serving as a calcium release
channel, thus they are involved in synaptic plasticity (Caillard
et al., 2000; Adasme et al., 2011) and functions in axon degen-
eration through mediating operations of GluR4 AMPA receptors
(Ouardouz et al., 2009). PTPRD and PTPRM encode recep-
tor protein tyrosine phosphatases delta and mu which are sig-
nificantly involved in neural development and axon guidance
(Ensslen-Craig and Brady-Kalnay, 2004). It is interesting to note
that, again the highlighted genes appear to converge on their
developmental roles.
Another significantly enriched pathway, LTD, involved GRID2
and three genes also participating in PKA signaling (RYR2, RYR3,
and PRKCB). GRID2 is a glutamate receptor known for its role
in synapse formation and LTD induction in cerebellum (Yuzaki,
2013). How it may relate to white matter integrity awaits fur-
ther investigations. The other three genes, as reviewed above,
have been implicated in both axonogenesis and synaptic plasticity,
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which is also documented for other genes (CREB, PTPRD, and
PTPRM) highlighted in the SNP component. While the SZ
neuropathology hypothesis based on altered brain connectivity
diverges in whether the dysconnection manifests anatomically
(through structural changes of association fibers) or functionally
(through aberrant control of synaptic plasticity), our observa-
tion suggested that these two factors might coexist (Stephan et al.,
2009). Despite that the FA-SNP association indicated these genes
contributing to structural dysconnectivity, their potential role in
abnormal synaptic regulation cannot be ruled out and deserves
further delineation.
The current study was limited in the following aspects. First,
the imaging data were collected at multiple sites with differ-
ent platforms. To address the potentially confounding site effect,
we performed a voxelwise regression to eliminate the related
effects and used the corrected data for P-ICA. Another limita-
tion lied in the admission of subjects with various ethnicities.
To avoid biased findings, we corrected the SNP data by elimi-
nating the ethnicity-related components. In the resulting FA-SNP
association, we did not observe any significant contribution from
ethnicity. Meanwhile, due to the limited sample size, the investi-
gation of FA-SNP associations focused on 6527 pre-filtered SNPs,
which is likely incomplete given the complex mechanisms under-
lying white matter abnormalities. Our finding depicts a part of
the picture. The observed SNP-FA association appeared to be
mainly driven by the group difference, given that no signifi-
cant correlation was observed in either patient or control group.
Specifically for the patient group, we included medication (i.e.,
chlorpromazine equivalents of current medication) in the regres-
sion model and did not observe any significant effect on the FA
loadings. Exploring further we found that the top paired SNP
component from P-ICA was found to be the second most signif-
icant component showing group difference, replicating reliably
in all subset evaluations. This could indicate the uniqueness in
FA-SNP component association other than the shared group dif-
ference, bringing forth the fact that FA changes are likely due to
genetic factors. However, other factors cannot be completely ruled
out in this work. Though premature, we might speculate that the
FA-SNP relationship is limited by the range of symptom severity
measures. The range for PANSS positive and negative symptoms
is 0–49 (Opler et al., 2006) and from Table 3 we observe that this
dataset could represent a population occupying a very narrow
slice of the schizophrenia spectrum. The association therefore,
might get stronger in a dataset that is more strongly psychotic.
Also, the unavailability of an independent dataset for replication
of results is a limitation, though we ascertained this to a certain
extent using 10-fold validation and permutation tests. FA-SNP
association presented here is the first step and future work will
involve investigation of complementary indices like axial diffu-
sivity and radial diffusivity, for association with genetic data. We
chose the FA approach as it enables a full characterization of
multivariate distribution of values. Future work may also focus
on the use of Tract Based Spatial Statistics, which provides a
much smaller set of values and removes data in a complex and
non-linear manner.
In conclusion, we consider this work one step further
toward understanding the genetic underpinnings of white matter
abnormalities in SZ, in part as it assessedmultiple genetic variants
for aggregate effects. More importantly, we revealed that this local
FA reduction was associated with a genetic factor enriched in CC
morphology, LTD and PKA signaling. The involved genes appear
to converge on developmental functions, indicating a possibil-
ity that genetic variants contribute to white matter abnormalities
through disrupting neural development. The fact that these genes
also participate in synaptic plasticity leads to the speculation of
functional dysconnectivity, which will be investigated in a future
study.
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